California State Teachers Retirement System Cuts Stock Position in The Cooper Companies, Inc. $COO

California State Teachers Retirement System lowered its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 13.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 271,371 shares of the medical device company's stock after selling 42,413 shares during the quarter. California State Teachers Retirement System owned 0.14% of Cooper Companies worth $19,460,014 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. New York Life Investment Management LLC lifted its position in shares of Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company's stock worth $2,241,000 after buying an additional 158 shares during the last quarter. Root Financial Partners LLC increased its position in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock worth $26,000 after acquiring an additional 162 shares during the period. Essential Partners LLC grew its position in Cooper Companies by 23.4% during the 1st quarter. Essential Partners LLC now owns 874 shares of the medical device company's stock worth $62,000 after acquiring an additional 166 shares during the last quarter. Allworth Financial LP increased its stake in Cooper Companies by 14.1% in the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company's stock valued at $111,000 after purchasing an additional 167 shares in the last quarter. Finally, SJS Investment Consulting Inc. boosted its position in Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock worth $26,000 after purchasing an additional 187 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

COO has been the topic of several recent research reports. Citigroup reaffirmed a "neutral" rating and issued a $60.00 price target (down from $80.00) on shares of Cooper Companies in a research note on Thursday, September 10th. Bank of America reaffirmed a "neutral" rating and issued a $65.00 price target (down from $80.00) on shares of Cooper Companies in a research note on Thursday, September 10th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Cooper Companies in a report on Friday, September 4th. Robert W. Baird set a $61.00 price target on Cooper Companies and gave the stock a "neutral" rating in a research report on Thursday, September 10th. Finally, Zacks Research downgraded Cooper Companies from a "hold" rating to a "strong sell" rating in a research note on Friday. Five analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Hold" and an average target price of $71.47.

Cooper Companies Trading Down 1.4%

NASDAQ:COO traded down $0.76 during trading hours on Tuesday, hitting $53.46. 1,965,194 shares of the company were exchanged, compared to its average volume of 2,487,251. The stock has a market capitalization of $10.17 billion, a price-to-earnings ratio of 18.24, a price-to-earnings-growth ratio of 2.19 and a beta of 0.82. The company has a fifty day simple moving average of $71.25 and a 200 day simple moving average of $69.40. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a one year low of $51.01 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%.Cooper Companies's revenue for the quarter was up .5% compared to the same quarter last year. During the same period last year, the firm posted $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 4.53 EPS for the current fiscal year.

Cooper Companies declared that its board has approved a stock buyback plan on Wednesday, September 9th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the medical device company to purchase up to 22.7% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's management believes its stock is undervalued.

Cooper Companies Company Profile

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.